| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000044438 |
| Receipt No. | R000050766 |
| Scientific Title | A PROSPECTIVE RANDOMIZED CLINICAL STUDY TO COMPARE THE EFFICACY OF 0.25% BUPIVACAINE WITH CLONIDINE AND 0.25% LEVOBUPIVACAINE WITH CLONIDINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERIES |
| Date of disclosure of the study information | 2021/06/04 |
| Last modified on | 2021/06/04 (Ver. 1) |
| Basic information | ||
| Public title | Comparision of Anesthetic drug combinations Bupivacaine with clonidine and Levobupivacaine with clonidine used in nerve blocks for surgeries of upper limb | |
| Acronym | Comparision of Anesthetic drug combinations Bupivacaine with clonidine and Levobupivacaine with clonidine used in nerve blocks for surgeries of upper limb | |
| Scientific Title | A PROSPECTIVE RANDOMIZED CLINICAL STUDY TO COMPARE THE EFFICACY OF 0.25% BUPIVACAINE WITH CLONIDINE AND 0.25% LEVOBUPIVACAINE WITH CLONIDINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERIES | |
| Scientific Title:Acronym | A PROSPECTIVE RANDOMIZED CLINICAL STUDY TO COMPARE THE EFFICACY OF 0.25% BUPIVACAINE WITH CLONIDINE AND 0.25% LEVOBUPIVACAINE WITH CLONIDINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERIES | |
| Region |
|
|
| Condition | |||
| Condition | ANAESTHESIA FOR UPPER LIMB SURGERIES | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The effects will be studied in 2 groups in terms of
1.Onset and duration of sensory block 2.Onset and duration of motor block 3.Hemodynamic changes 4.Assessment of pain 5.Adverse effects if any |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase IV |
| Assessment | |
| Primary outcomes | Measure the Onset and duration of action between combination of 0.25% Bupivacaine with Clonidine and 0.25% Levobupivacaine with Clonidine in Supraclavicu;ar Brachial plexus block for upper limb surgeries.
Onset was measured every minute after giving supraclavicular brachial plexus block Duration was measured until complete recovery from supraclavicular brachial plexus block using Bromage scale |
| Key secondary outcomes | 1. Hemodynamic changes mainly systolic blood pressure, diastolic blood pressure, Mean arterial blood pressure and Peripheral oxygen saturation SpO2 are measured Intraoperatively every 5 minutes and Postoperatively every hourly upto 24 hours between the study groups
2.Postoperative Assessment of pain with the use of Visual analogue scale was measured every hourly upto 24 hours. 3. Occurance of any adverse events were notes |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Dose comparison |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | YES |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Group BC: recieved 30 ml of 0.25% Bupivacaine with 1microgram/kg Clonidine for supraclavicular brachial plexus block for upper limb surgeries | |
| Interventions/Control_2 | Group LC: recieved 30 ml of 0.25% Levoupivacaine with 1microgram/kg Clonidine for supraclavicular brachial plexus block for upper limb surgeries | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients aged between 18 to 60 years of either sex.
2.ASA physical status I-II 3.Elective upper limb surgeries |
|||
| Key exclusion criteria | 1.Patient refusal for procedure
2.Any bleeding disorder or patient on anticoagulants 3.Neurological deficits involving brachial plexus 4.Patients with allergy to local anaesthetics 5.Local infection at the injection site 6.Patients on any adrenoreceptor agonist or antagonist therapy 7.Patients weighing less than 35kgs 8.Body mass index >35 9.Pregnant women |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | K.V.G. MEDICAL COLLEGE AND HOSPITAL | ||||||
| Division name | DEPARTMENT OF ANAESTHESIOLOGY | ||||||
| Zip code | 574327 | ||||||
| Address | KURUNJIBAG, SULLIA,DK | ||||||
| TEL | 08257232404 | ||||||
| kvgmedc@yahoo.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | K.V.G. MEDICAL COLLEGE AND HOSPITAL | ||||||
| Division name | DEPARTMENT OF ANAESTHESIOLOGY | ||||||
| Zip code | 574327 | ||||||
| Address | KURUNJIBAG, SULLIA,DK | ||||||
| TEL | 7795098801 | ||||||
| Homepage URL | |||||||
| drabhishekservices@gmail.com | |||||||
| Sponsor | |
| Institute | K.V.G. MEDICAL COLLEGE AND HOSPITAL
DEPARTMENT OF ANAESTHESIOLOGY |
| Institute | |
| Department | |
| Funding Source | |
| Organization | K.V.G. MEDICAL COLLEGE AND HOSPITAL
DEPARTMENT OF ANAESTHESIOLOGY |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | K.V.G. MEDICAL COLLEGE AND HOSPITAL |
| Address | KURUNJIBAG- 574327, SULLIA, DK |
| Tel | 08257232404 |
| kvgmedc@yahoo.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 80 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050766 |